Literature DB >> 21418268

Elevation of liver enzymes within the normal limits and metabolic syndrome.

Ming-Feng Xia1, Hong-Mei Yan, Huan-Dong Lin, Hua Bian, Bai-Shen Pan, Xiu-Zhong Yao, Ruo-Kun Li, Meng-Su Zeng, Xin Gao.   

Abstract

1. Metabolic syndrome is frequently associated with elevated liver enzymes. However, the current 'normal' limits for liver enzymes often fail to identify patients with metabolic syndrome and the associated non-alcoholic fatty liver disease (NAFLD). 2. In the present study, 1503 participants, aged between 18 and 95 years, were recruited from the physical examination centre of Shanghai Zhongshan Hospital and Shanghai Changfeng Community Health Centre. The association between liver enzymes within the 'normal' range and metabolic syndrome was investigated and optimal cut-off values for liver enzymes in metabolic syndrome were determined. We further compared the diagnostic performance of the new cut-off values for liver enzymes in metabolic syndrome and NAFLD with the traditional 'normal' range for liver enzymes. 3. Serum liver enzymes within the traditional 'normal' limits, especially alanine aminotransferase (ALT) and γ-glutamyl transpeptidase (GGT), were correlated with most of components of the metabolic syndrome, as determined by Spearman's partial correlation analysis. Logistic regression analysis revealed that within the 'normal' range of liver enzymes, the frequency of metabolic syndrome was significantly increased in the higher quintile for ALT and GGT compared with the lowest quintile. Receiver operating characteristic curve analysis revealed that the optimal cut-off values for ALT, aspartate aminotransferase and GGT to identify metabolic syndrome were 26, 25 and 29 U/L, respectively, in men and 20, 23 and 21 U/L, respectively, in women. These values were much more effective in detecting patients with potential metabolic syndrome and NAFLD than the traditional cut-off values. 4. A slight elevation of liver enzymes within the 'normal' limits, especially ALT and GGT, indicates the presence of metabolic syndrome and NAFLD. Revision of the current normal limits for liver enzymes is advisable so that patients with potential metabolic disorders can be identified.
© 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418268     DOI: 10.1111/j.1440-1681.2011.05519.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  14 in total

1.  Indicators of fetal growth and adult liver enzymes: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study.

Authors:  E W Harville; W Chen; L Bazzano; M Oikonen; N Hutri-Kähönen; O Raitakari
Journal:  J Dev Orig Health Dis       Date:  2016-12-06       Impact factor: 2.401

2.  Association between serum apolipoprotein B and atrial fibrillation: a case-control study.

Authors:  Xia Zhong; Huachen Jiao; Dongsheng Zhao; Jing Teng
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

3.  Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation.

Authors:  Moritz F Sinner; Na Wang; Caroline S Fox; João D Fontes; Michiel Rienstra; Jared W Magnani; Ramachandran S Vasan; Audrey H Calderwood; Michael Pencina; Lisa M Sullivan; Patrick T Ellinor; Emelia J Benjamin
Journal:  Am J Cardiol       Date:  2012-11-02       Impact factor: 2.778

4.  γ-glutamyl transpeptidase in men and alanine aminotransferase in women are the most suitable parameters among liver function tests for the prediction of metabolic syndrome in nonviral hepatitis and nonfatty liver in the elderly.

Authors:  Dee Pei; Te-Lin Hsia; Ting-Ting Chao; Jiunn-Diann Lin; Chun-Hsien Hsu; Chung-Ze Wu; Chang-Hsun Hsieh; Yao-Jen Liang; Yen-Lin Chen
Journal:  Saudi J Gastroenterol       Date:  2015 May-Jun       Impact factor: 2.485

5.  Reducing Liver Fat by Low Carbohydrate Caloric Restriction Targets Hepatic Glucose Production in Non-Diabetic Obese Adults with Non-Alcoholic Fatty Liver Disease.

Authors:  Haoyong Yu; Weiping Jia; ZengKui Guo
Journal:  J Clin Med       Date:  2014-09       Impact factor: 4.241

6.  Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver.

Authors:  Minoru Tomizawa; Yuji Kawanabe; Fuminobu Shinozaki; Sumihiko Sato; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi
Journal:  Exp Ther Med       Date:  2014-06-23       Impact factor: 2.447

7.  Beneficial effects of an 8-week, very low carbohydrate diet intervention on obese subjects.

Authors:  Yunjuan Gu; Haoyong Yu; Yuehua Li; Xiaojing Ma; Junxi Lu; Weihui Yu; Yunfeng Xiao; Yuqian Bao; Weiping Jia
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-14       Impact factor: 2.629

8.  SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose.

Authors:  Taku Fukuzawa; Masanori Fukazawa; Otoya Ueda; Hideaki Shimada; Aki Kito; Mami Kakefuda; Yosuke Kawase; Naoko A Wada; Chisato Goto; Naoshi Fukushima; Kou-Ichi Jishage; Kiyofumi Honda; George L King; Yoshiki Kawabe
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

9.  Alanine aminotransferase is associated with an adverse nocturnal blood glucose profile in individuals with normal glucose regulation.

Authors:  Jian Zhou; Yifei Mo; Hong Li; Xingwu Ran; Wenying Yang; Qiang Li; Yongde Peng; Yanbing Li; Xin Gao; Xiaojun Luan; Weiqing Wang; Weiping Jia
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

10.  Serum aminotransferase levels in healthy population from western India.

Authors:  Satish Kumar; Anjali Amarapurkar; Deepak Amarapurkar
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.